A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...

While the current state of the art in retinal implants is better than total blindness, it is still a long way from anything approaching normal vision. But two researchers have teamed up to improve ...

Please provide your email address to receive an email when new articles are posted on . Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The groundbreaking device, called PRIMA, has partially restored vision in people ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

LOS ANGELES (KABC) -- At 17, Jirair Semerdijan of Henderson, Nevada completely lost his sight to retinitis pigmentosa. The condition destroyed part of his retina. He lost his sight and his ...

Researchers at the USC Roski Eye Institute, part of Keck Medicine of USC, are launching a phase 2b clinical trial examining if stem cells bioengineered to replace failing cells in the retina damaged ...

Scientists have used an eye implant to improve the vision of dozens of people left functionally blind by age-related macular degeneration (AMD). The implant, which measures 2 millimetres by 2 ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved a dexamethasone 0.7-mg intravitreal implant (Ozurdex, Allergan, Inc) for the treatment of macular edema after branch ...